Skip to main content

Table 4 Causes of treatment failure in different groups

From: Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma

No. of patients experiencing failure (%)

Disease recurrence

CT-suspect group (n=84)

CT-negative group (n=210)

χ2 value

P value

Total

 

50 (59.5%)

77 (36.7%)

12.775

<0.001*

Local

 

40 (47.6%)

53 (25.2%)

13.897

<0.001*

 

Sup.LN

19 (22.6%)

10 (4.8%)

21.519

<0.001*

 

Med.LN

17 (20.2%)

37 (17.6%)

0.274

0.600

 

Abd.LN

5 (6%)

5 (2.4%)

1.369

0.155

 

Tumor bed

2 (2.4%)

4 (1.9%)

0.000

1.000

 

Ana

4 (4.8%)

2 (1.0%)

2.658

0.058

Metastasis

 

18 (21.4%)

35 (16.7%)

0.921

0.337

  1. CT computed tomography; Sup supraclavicular; Med mediastinal; Abd abdominal; Ana anastomotic; LN lymph node
  2. *P value < 0.05